Global Hydroxychloroquine Market Projected to Reach Over USD 2,598.6 Million by 2028 - Vantage Market Research


WASHINGTON, Feb. 16, 2022 (GLOBE NEWSWIRE) -- The Global Hydroxychloroquine Market size is expected to reach over USD 2,598.6 Million by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period.

Market Synopsis

The Hydroxychloroquine Market globally is driven majorly by high prevalence of such situations, especially in the emerging nations of Southeast Asia and Africa. Additionally, it has seen a sudden boost in demand, due to some of the restricted-scale studies which proved its efficacy opposite to COVID-19 virus. Nonetheless, a lot more clinical trials and tests are required before Hydroxychloroquine commercializes as the drug for COVID-19 treatment, states Vantage Market Research, in a report, titled “Hydroxychloroquine Market by Application (Coronavirus Disease (COVID-19), Malaria, Lupus Erythematosus, Rheumatoid Arthritis), by Distribution Channel (Online Pharmacy, Hospital Pharmacy, Retail Pharmacy), by Region (North America, Latin America, Europe, Asia Pacific) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)”. The Hydroxychloroquine Market stood at USD 901.4 Million in the year 2021.

Click Here To Access The Free Sample Report @ https://www.vantagemarketresearch.com/hydroxychloroquine-market-1265/request-sample

(The Free Sample Of This Report Is Readily Available On Request).

Our Free Sample Reports Includes:

  • In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
  • Impact Analysis 160+ Pages Research Report (Including latest research)
  • Provide chapter-wise guidance on request 2021 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
  • Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Vantage Market Research methodology.

(Please note that the sample of this report has been updated to include the COVID-19 impact study prior to delivery.)

List Of Prominent Players in the Hydroxychloroquine Market:

  • Sanofi
  • Amneal Pharmaceuticals, Inc.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Zydus Cadila
  • Dr. Reddy’s Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Limited
  • Prasco Laboratories

Market Dynamics:

Driver: Rise in Spread of Diseases Like, Covid-19, and Malaria

The Hydroxychloroquine Market growth enhanced by the increasing cases of contagious diseases that includes majorly malaria and coronavirus and expanded R&D. In addition, advancements in the treatment choices and existence of well-established facilities in healthcare are some of the impacting determinants for the Hydroxychloroquine drugs demand. Nevertheless, discontinuation and product recalls of drugs are also the factors which can hinder the market growth.

Hydroxychloroquine is an analogue and medication of chloroquine. It has antimalarial as well as antirheumatic features. It has been widely used for the treatment of rheumatoid arthritis as well. It has been acknowledged that clinical use of the drug Hydroxychloroquine has substantially enhanced the treatment proportion of patient who are suffering from COVID-19.

Purchase This Premium Report Now @ https://www.vantagemarketresearch.com/buy-now/hydroxychloroquine-market-1265/1

Benefits of Purchasing Hydroxychloroquine Market Reports:

  • Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.
  • Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.
  • Assured Quality: Focuses on accuracy and quality of reports.
  • Incomparable Skills: Analysts provide in-depth insights into reports.

Restraint: Side Effects with the Use of Hydroxychloroquine

One of the key factors hampering the market growth for Hydroxychloroquine is side effects which are related with the use of it. In addition, the clinical efficacy via randomized clinical is not assessed for harmful effects in COVID-19. The ambivalence of effects which are long term is likely to harm the market growth for Hydroxychloroquine Market. Studies have shown the side effects associated with the use of this drug which are, cardiac problem, diarrhea, stomach ache, and other side effects due to its prolonged use.

Regional Trends

North America is likely to witness an upward growth for Hydroxychloroquine Market during the forecasted period due to high occurrence of malaria and increase in the demand for Hydroxychloroquine drug for the treatment of coronavirus. North-America is likely to be the second largest expanding regional segment owing to the existence of high diagnostic rate and refined healthcare infrastructure.

Read Full Research Report @ https://www.vantagemarketresearch.com/industry-report/hydroxychloroquine-market-1265

Recent Developments

  • June, 2021: Catalent, Inc. announced the acquisition of RheinCell Therapeutics Gmbh, a leading developer and manufacturer of GMP Grade human induced pluripotent stem cells. This acquisition will help the company’s existing stem cell therapy process development and manufacturing capabilities.
  • Dec, 2020: Lonza announced an expansion and collaboration with Arunia pharmaceuticals in order to expand a manufacturing capacity for an efficient production and manufacturing of Voclosporin.
  • July, 2020: The USFDA cautioned against the use of hydroxycloroquine and chloroquine to treat hospitalized COVID-19 patients due to risk of heart rhythm problems, blood and lymph system disorders, liver failure and problems, and kidney injuries.

COVID-19 Impact Analysis:

The COVID-19 outbreak has affected various industries worldwide. Governments across the world implemented strict lockdown measures and social distancing norms in order to restrict the swift spread of the pandemic. Manufacturing facilities around the world were shut down during the initial stages of the pandemic. Moreover, the economic crisis after the pandemic might lead to a significant delay in the commercial roll-out of the Hydroxychloroquine Market. Hence, market players faced numerous challenges as disruptions in the supply chain were observed. However, things will improve in the second half of 2022 as more supplies will come online. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends of the market for all the regions and countries based on the following data points:

  1. Impact Assessment of COVID-19 Pandemic
    1. North America
    2. Europe
    3. Asia Pacific
    4. Latin America
    5. Middle East & Africa
  2. Quarterly Market Revenue Forecast by Asia Pacific 2020 & 2021
  3. Key Strategies Undertaken by Companies to Tackle COVID-19
  4. Long Term Dynamics
  5. Short Term Dynamics

Browse market data Tables and Figures spread through 167 Pages and in-depth TOC on "Hydroxychloroquine Market by Application (Coronavirus Disease (COVID-19), Malaria, Lupus Erythematosus, Rheumatoid Arthritis), by Distribution Channel (Online Pharmacy, Hospital Pharmacy, Retail Pharmacy), by Region (North America, Latin America, Europe, Asia Pacific) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)" View detailed Research Report here - https://www.vantagemarketresearch.com/press-release/hydroxychloroquine-market-833138

The report on Hydroxychloroquine Market highlights:

  • Assessment of the market
  • Premium Insights
  • Competitive Landscape
  • COVID Impact Analysis
  • Historic Data, Estimates and Forecast
  • Company Profiles
  • Global and Regional Dynamics

Key questions answered in the report:

  • Which regional market will show the highest and rapid growth?
  • Which are the top five players of the Hydroxychloroquine Market?   
  • How will the Hydroxychloroquine Market change in the upcoming six years?  
  • Which application and product will take a lion’s share of the Hydroxychloroquine Market?     
  • What is the Hydroxychloroquine market drivers and restrictions?    
  • What will be the CAGR and size of the Hydroxychloroquine Market throughout the forecast period?   

This market titled “Hydroxychloroquine Market” will cover exclusive information in terms of, Regional Analysis, Forecast, and Quantitative Data – Units, Key Market Trends, and various others as mentioned below:

Report AttributeDetails
Market Size in 2021USD 901.4 Million
Projected Market Size in 2028USD 2,598.6 Million
CAGR Growth RateCAGR of 5.7% From 2022 - 2028
Base Year2021
Historic Years2016 – 2020
Forecast Years2022 – 2028
Segments CoveredApplication
  • Coronavirus Disease (COVID-19)
  • Malaria
  • Lupus Erythematosus
  • Rheumatoid Arthritis
Distribution Channel
  • Online Pharmacy
  • Hospital Pharmacy
  • Retail Pharmacy
Quantitative Data - UnitsRevenue in USD Million/Billion and CAGR from 2022 to 2028
Regions CoveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries CoveredU.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered10 companies with scope for including additional 15 companies upon request
Report CoverageMarket growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization of the Report:

The report can be customized as per client needs or requirements. For any queries, you can contact us on sales@vantagemarketresearch.com or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.

Download Free Sample Report Now @ https://www.vantagemarketresearch.com/hydroxychloroquine-market-1265/request-sample

Browse More Related Report:

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.

Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/

Follow Us on Twitter: https://twitter.com/vantagemarketr

Contact us

Eric Kunz

6218 Georgia Avenue NW Ste 1 - 564

Washington DC 20011-5125

United States Tel: +1 202 380 9727

Email: sales@vantagemarketresearch.com

Website: https://www.vantagemarketresearch.com/

Latest Vantage Market Research Press Releases @ https://www.vantagemarketresearch.com/insight/press-releases

Latest Vantage Market Research Blog @ https://www.vantagemarketresearch.com/insight/blogs

Blog: